Medical/Pharmaceuticals
Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device
YOKNEAM, Israel, May 7, 2019 /PRNewswire/ -- Rapid Medical
2019-05-07 09:00
1457
Innovation Tour on Medical Design and Manufacturing; Medtec China 2019 Visitor Registration Initiated
SHANGHAI, May 7, 2019 /PRNewswire/ -- The 15th Exhibition of Medical Device Design & Manufacturing inChina (Medtec China 2019) will be held from September 25–27 inShanghai. As a leading international exhibition of medical device design and manufacturing inChina, Medtec China will gather 450+ exhi...
2019-05-07 09:00
2238
Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore
Launch of Activated Form of Critical Bacteria B. Infantis in Asia Fulfills Li Ka Shing Foundation's Vision, Caps First Quarter of Major Activity in the Continent DAVIS, California, May 7, 2019 /PRNewswire/ -- Evolve BioSystems, makers of Evivo® baby probiotic, today announced that its flagship c...
2019-05-07 05:00
2044
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certifi...
2019-05-06 21:00
1962
Bardy Diagnostics Earns Acclaim from Frost & Sullivan for Its Groundbreaking Carnation Ambulatory Monitor™ Patch for Arrhythmia Monitoring
CAM™'s unique P-wave-centric ECG monitor offers unmatched signal clarity and superior arrhythmia detection SANTA CLARA, California, May 6, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote cardiac monitoring market, Frost & Sullivan recognizesBardy Diagnostics, Inc. ...
2019-05-06 20:00
1265
Frost & Sullivan Publishes Annual Update on Cellect
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 18:11
858
Frost & Sullivan Publishes Annual Update on Brainsway
TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...
2019-05-06 17:57
857
Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201
TAICANG, China, May 6, 2019 /PRNewswire/ -- Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody, CBP-201. The randomized, double-blind, placebo-controlled study, conducted inMelbourne, Australia, evaluated t...
2019-05-06 17:00
881
Scientific Advisory Board Announced for DELopen to Guide the Open Access DNA Encoded Library Interchange
SHANGHAI and BOSTON, May 6, 2019 /PRNewswire/ -- DELopen, a new platform dedicated to the hit generation of drug discovery of DNA Encoded Library (DEL) Technology, has announced the formation of its Scientific Advisory Board. The board, chaired by Dr. Richard Lerner, Institute Professor of Scripp...
2019-05-06 13:38
1426
Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, May 6, 2019 /PRNewswire/ -- Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. (CTTQ) today announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics for multiple thera...
2019-05-06 10:49
1763
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
SHANGHAI and SAN DIEGO, May 5, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired Pharmapace, Inc., a US-based clinical research services company with expertise of provid...
2019-05-06 07:50
2561
Ortoma Engages M&A Advisor
STOCKHOLM, May 2, 2019 /PRNewswire/ -- Ortoma and the Board of Directors have engaged MedWorld Advisors (www.medworldadvisors.com ) as M&A advisor to assist the company and the Board with management, evaluations, and negotiations in connection with any M&A transaction. During the past year, the ...
2019-05-02 15:32
5587
Concept Medical Inc. Granted 'Breakthrough Device Designation' From FDA for Its MagicTouch Sirolimus Coated Balloon
TAMPA, Fla., May 2, 2019 /PRNewswire/ -- Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) forMagicTouch, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of coronary in-stent restenosis (ISR). In-ste...
2019-05-02 15:00
1792
CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
SUZHOU, China and ZURICH, May 2, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) and Numab Therapeutics AG ("Numab") today announce that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND021, a potential best-in-clas...
2019-05-02 11:05
3606
Beckman Coulter Introduces Total Laboratory Automation Solution That Sets New Standard for Turnaround Time
The DxA 5000 delivers rapid and consistent turnaround time, provides the industry's most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif., May 2, 2019 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today...
2019-05-02 08:00
2669
Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments SUNNYVALE, California, May 2, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with...
2019-05-02 04:10
6163
binx health Receives CE Mark For Rapid Chlamydia And Gonorrhea Test For Mass Markets
Multiplex Test Panel for binx io® Point-of-Care Platform Positioned to Radically Reduce Time to Treatment, Expand Access to Care BOSTON, May 2, 2019 /PRNewswire/ -- binx health™, the pioneer in anywhere care today announced that its proprietary Chlamydia and Gonorrhea (CT/NG) test has received E...
2019-05-02 03:11
2230
3-V Biosciences Commences Dosing in Phase 2 Clinical Study of the FASN Inhibitor TVB-2640 in Patients with NASH
SAN MATEO, Calif. and HANGZHOU and SHAOXING, China, May 1, 2019 /PRNewswire/ -- 3-V Biosciences, Inc. (3-V Biosciences) and Ascletis Pharma Inc. (Ascletis, 1672.HK)announced that 3-V Biosciences has recently dosed its first patient in a Phase 2 clinical trial of the FASN (fatty acid synthase) inh...
2019-05-01 06:00
5857
Nimble Therapeutics Spins Out from Roche to Commercialize Novel Drug Discovery Technology with Financing from Telegraph Hill Partners
MADISON, Wisconsin, April 30, 2019 /PRNewswire/ -- Nimble Therapeutics has begun operating as a standalone business after spinning out from F. Hoffmann La Roche (SIX: RO, ROG; OTCQX: RHHBY) to commercialize its proprietary chemical synthesis technology for drug discovery and development. The comp...
2019-04-30 22:00
7849
Tessa Therapeutics, in Collaboration with Baylor College of Medicine, Presents Preclinical Results Showing Enhanced T Cell Responses Against HER2-Positive Solid Tumors Using Novel Combination CAR T Cell Therapy
* Preclinical, 'proof-of-concept' results for a novel 'all-in-one' immunotherapy for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-positive solid tumors * The preclinical findings support the advancement of this multimodal immunotherapy into a Phase I clinical trial SINGAPO...
2019-04-30 22:00
2385
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7862
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6955
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4242
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2819